Drug monitoring of mycophenolic acid in the early period after renal transplantation
- 1 August 1998
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (5) , 1773-1774
- https://doi.org/10.1016/s0041-1345(98)00425-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF REFRACTORY, ACUTE, CELLULAR RENAL TRANSPLANT REJECTION1Transplantation, 1996
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- 193 FEASIBILITY OF AN EMIT® ASSAY FOR MYCOPHENOLIC ACID IN PLASMATherapeutic Drug Monitoring, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995